10:46 AM
 | 
Oct 19, 2018
 |  BC Week In Review  |  Company News  |  Other News

Trump signs law intended to deter 'pay-for-delay' deals for biosimilars

President Donald Trump signed the Patient Right to Know Drug Prices Act (S.2554) into law on Oct. 10, which includes a provision to make it more difficult for branded...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >